Mini telescope implant study for advanced age-related macular loss
Part of Eyes & vision clinical trials.
This post-approval study tests whether an implantable mini telescope can improve vision in people with advanced age-related macular degeneration that affects the center of vision. You may qualify if your vision loss matches a specific pattern and you can complete required eye training before and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 65 or older.
- Your vision loss is due to end-stage age-related macular degeneration affecting both eyes’ central vision (bilateral central scotomas).
- Your eye exam shows geographic atrophy or a scar involving the center (fovea), and you have a vision-impairing cataract.
- You need to be able to improve at least 5 letters using an external telescope during a screening test.
- You have usable side (peripheral) vision in the eye planned for surgery, and you can do the study’s training and assessments before and after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This post-market study looks at how well a telescope-like eye implant (NG SI IMT 3X) works for people with very advanced age-related macular degeneration that affects the center of vision, plus cataracts. The implant is placed in one eye, and you’ll get training to learn how to use it after surgery.
This study tests a device that is surgically implanted in the eye of people with late-stage age-related macular degeneration (AMD). It also uses vision training with a telescope-like tool to see if the treatment can improve day-to-day vision.
This trial tests a small telescope implant for people with advanced age-related macular degeneration (AMD) in both eyes. It aims to improve central vision in the eye where the implant is placed.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
This trial tests a patch of retinal cells implanted under the retina to see if it can slow or stop vision loss from advanced dry AMD (geographic atrophy). It may help people whose central vision is already affected.
This trial is testing a new eye implant (TO-O-1007) to see if it's safe and helps slow vision loss from geographic atrophy, a late stage of dry age-related macular degeneration (AMD). The implant is placed inside the eye and releases medicine over time.
Hear when a new AMD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.